文献速递心脏核医学

心脏磁共振成像与氟脱氧葡萄糖正电子发射断层显像评估心肌存活性的比较:荟萃分析与系统评价

Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
PubMed 文献 · J Nucl Cardiol · 2023-09-27

该系统评价与荟萃分析比较了对比增强心脏磁共振(Ce-CMR)与氟脱氧葡萄糖正电子发射断层显像(FDG-PET)评估心肌存活性的诊断参数,纳入4项研究共82例患者、585个节段。Ce-CMR预测心肌恢复的敏感度和特异度分别为0.88(95%CI 0.66-0.96)和0.64(95%CI 0.49-0.77),FDG-PET分别为0.91(95%CI 0.63-0.99)和0.67(95%CI 0.49-0.81),两者诊断参数相当。

要点

  • 纳入4项研究共82例患者、585个节段,比较Ce-CMR与FDG-PET评估心肌存活性。
  • Ce-CMR预测心肌恢复的敏感度0.88(95%CI 0.66-0.96),特异度0.64(95%CI 0.49-0.77)。
  • FDG-PET预测心肌恢复的敏感度0.91(95%CI 0.63-0.99),特异度0.67(95%CI 0.49-0.81)。

核心结论

  • FDG-PET与Ce-CMR在心肌存活性评估中具有相当的诊断参数,且与既往研究一致。

研究设计与样本

  • 检索PubMed、EMBASE、Scopus和Web of Science数据库自建库至2022年4月20日的文献,检索词为「viability」和「heart diseases」和「cardiac magnetic resonance imaging」和「positron-emission tomography」。
  • 纳入4项研究,共82例患者、585个节段进行存活性评估比较。
  • 患者中男性59例(72%),平均年龄65岁。

主要发现

  • Ce-CMR预测心肌恢复的敏感度为0.88(95%CI 0.66-0.96),特异度为0.64(95%CI 0.49-0.77)。
  • FDG-PET预测心肌恢复的敏感度为0.91(95%CI 0.63-0.99),特异度为0.67(95%CI 0.49-0.81)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Contrast-enhanced cardiac magnetic resonance (Ce-CMR) and Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) are frequently utilized in clinical practice to assess myocardial viability. However, studies evaluating direct comparison between Ce-CMR and FDG-PET have a smaller sample size, and no clear distinction between the two imaging modalities has been defined. To address this gap, we conducted a meta-analysis of studies comparing Ce-CMR and FDG-PET for the assessment of myocardial viability. METHODS: We searched PubMed, EMBASE, Scopus, and Web of Science databases from their inception to 4/20/2022 with search terms "viability" AND "heart diseases" AND "cardiac magnetic resonance imaging" AND "positron-emission tomography." We extracted patient characteristics, segment level viability assessment according to Ce-CMR and FDG-PET, and change in regional wall motion abnormalities (RWMA) at follow-up. RESULTS: We included four studies in the meta-analysis which provided viability assessment with Ce-CMR and FDG-PET in all patients and change in RWMA at follow-up. There were 82 patients among the four included studies, and 585 segments were compared for viability assessment. There were 59 (72%) males, and mean age was 65 years. The sensitivity (95% confidence interval-CI) and specificity (CI) of Ce-CMR for predicting myocardial recovery were 0.88 (0.66-0.96) and 0.64 (0.49-0.77), respectively. The sensitivity (CI) and specificity (CI) of FDG-PET for predicting myocardial recovery were 0.91 (0.63-0.99) and 0.67 (0.49-0.81), respectively. CONCLUSION: FDG-PET and Ce-CMR have comparable diagnostic parameters in myocardial viability assessment and are consistent with prior research.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Adhaduk M, Paudel B, Liu K, et al. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review. J Nucl Cardiol. 2023. PMID: 37758962. doi:10.1007/s12350-023-03377-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。